CoChat

Preoperative oral carbohydrate (CHO) supplementation is beneficial for clinical and biochemical outcomes in patients undergoing elective cesarean delivery under spinal anaesthesia-a randomized controlled trial

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Background: Preoperative fasting and surgery cause metabolic stress, insulin resistance with ketosis, and postoperative nausea and vomiting (PONV). Oral carbohydrate loading strategy (CHO) improves outcomes in labor and general surgery. We aimed to compare the effectiveness of CHO with standard fasting in patients undergoing elective cesarean delivery (CD) under spinal anesthesia. Methods: A single-center, parallel, prospective randomized controlled trial (RCT) was conducted in a tertiary university obstetrics department at Pomeranian Medical University in Szczecin, Poland. Patients were randomly assigned (1:1 ratio) to the CHO group (oral carbohydrate 2 h before elective CD, n = 75) or the SF group (control—standard fasting, n = 73). The main outcome measures were incidence and severity of PONV at 6 and 24 h after CD, time to the first peristalsis, time to first bowel movement, and biochemical parameters indicating ketosis in mothers and their children. Results: A total of 148 adult females with singleton pregnancies undergoing elective CD under spinal anesthesia (ASA I and II) were included in the final analysis. At 24 h after CD, 8.0% from the CHO group vs. 20.55% reported three or more episodes of vomiting or dry retching as compared to patients in the SF group (p = 0.041). Preoperative CHO supplementation decreased preoperative feelings of hunger (p < 0.001) and thirst (p < 0.001). Laboratory results in the CHO group showed higher plasma pH (p = 0.001) and glucose (p < 0.001), lower F2-isoprostane in plasma (p = 0.049) and urine (p = 0.018), lower urine F2-isoprostane/creatinine ratio (p = 0.045) than in the SF group. HOMA-IR (p < 0.001) and lactate (p < 0.001) were higher in the CHO group than in the control group. Conclusions: There was no significant difference in the incidence or severity of early PONV at 6 h. The incidence of vomiting or dry retching at 24 h after cesarean delivery was lower in the CHO group as compared to standard starvation, but the combined results of PONV frequency and severity on the Wengritzky scale did not differ between the two study groups. Preoperative CHO supplementation decreased preoperative feelings of hunger and thirst, enhancing the comfort of pregnant women. Trial registration: ClinicalTrials.gov identifier: NCT04069806.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm12154978

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 CONSORT flow diagram of the progress through stages of a randomized controlled trial of two parallel groups.
Figure 1 CONSORT flow diagram of the progress through stages of a randomized controlled trial of two parallel groups.CC BY · PubMed Central
Figure 2 (a) The pH level in maternal plasma. (b) The fasting glucose level in maternal plasma. The ketosis marker, i.e., the level of F2-isoprostane, was significantly lower in patients receiving CHO both in plasma (40.15 ± 16.89 vs. 43.78 14.91; p = 0.049) and in urine (615.42 ± 115.11 vs. 649.97 ± 121.41; p = 0.018), as was the urine F2-isoPs/creatinine ratio (1.896.12 ± 797.12 vs. 2.073.46 ± 701.84; p = 0.045) (c–e). (c) The F2-isoPs level in maternal plasma. (d) The F2-isoPs level in maternal urine. (e) The F2-isoPs/creatinine ratio in maternal urine. Interestingly, the insulin resistance index, HOMA-IR, was statistically significantly higher in the CHO group (10.45 ± 8.94 vs. 2.19 ± 1.15, p < 0.001) than in the control group (f), as was the serum lactate level in the study group (1.62 ± 0.49 mmol/L vs. 1.21 ± 0.46 mmol/L, p < 0.001) compared to the control group as shown in (g), although statistically different does not seem to be clinically significant. (f) HOMA-IR in maternal plasma. (g) Lactate level in maternal plasma. Quite contrary to mothers’ glucose levels, the analysis of neonatal data showed that in the group of mothers who received CHO, the level of glucose in the newborn’s capillary blood was lower, than in the newborns whose mothers did not receive CHO (52.10 mg/dL vs. 55.76 mg/dL, p = 0.007). (h) The glucose level in neonatal capillary blood.
Figure 2 (a) The pH level in maternal plasma. (b) The fasting glucose level in maternal plasma. The ketosis marker, i.e., the level of F2-isoprostane, was significantly lower in patients receiving CHO both in plasma (40.15 ± 16.89 vs. 43.78 14.91; p = 0.049) and in urine (615.42 ± 115.11 vs. 649.97 ± 121.41; p = 0.018), as was the urine F2-isoPs/creatinine ratio (1.896.12 ± 797.12 vs. 2.073.46 ± 701.84; p = 0.045) (c–e). (c) The F2-isoPs level in maternal plasma. (d) The F2-isoPs level in maternal urine. (e) The F2-isoPs/creatinine ratio in maternal urine. Interestingly, the insulin resistance index, HOMA-IR, was statistically significantly higher in the CHO group (10.45 ± 8.94 vs. 2.19 ± 1.15, p < 0.001) than in the control group (f), as was the serum lactate level in the study group (1.62 ± 0.49 mmol/L vs. 1.21 ± 0.46 mmol/L, p < 0.001) compared to the control group as shown in (g), although statistically different does not seem to be clinically significant. (f) HOMA-IR in maternal plasma. (g) Lactate level in maternal plasma. Quite contrary to mothers’ glucose levels, the analysis of neonatal data showed that in the group of mothers who received CHO, the level of glucose in the newborn’s capillary blood was lower, than in the newborns whose mothers did not receive CHO (52.10 mg/dL vs. 55.76 mg/dL, p = 0.007). (h) The glucose level in neonatal capillary blood.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 22

Metadata

Authors
Kotfis, K., Wojciechowska, A., Zimny, M., Jamioł-Milc, D., Szylińska, A., Kwiatkowski, S., Kaim, K., Dołęgowska, B., Stachowska, E., Zukowski, M., Pankowiak, M., Torbé, A., & Wischmeyer, P.
Affiliations
  • Pomeranian Medical University (PL)
  • Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland
  • Department of Obstetrics and Gynecology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland
  • Duke University (US)
Corresponding author
Kotfis, Katarzyna
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2023-07-28
Volume
12
Issue
15
Pages
4978
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4385421183
Cited by
18
References
44
Citations by year
2026: 8 · 2025: 7 · 2024: 3
FWCI
4.81
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Nutricia Polska Sp. z o.o. (CRU/1605/2019/Kw)
Topics
  • Health Sciences › Medicine › Surgery › Enhanced Recovery After Surgery
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
Keywords
elective cesarean section, spinal anesthesia, postoperative nausea and vomiting, preoperative fasting, ketosis, F2-isoprostanes, insulin resistance, HOMA-IR, lactate, postoperative bowel function, maternal and neonatal outcomes, obstetric surgery, metabolic stress, postoperative recovery time

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Preoperative oral carbohydrate (CHO) supplementation is beneficial for clinical and biochemical outcomes in patients undergoing elective cesarean delivery under spinal anaesthesia-a randomized controlled trial. https://app.cochat.ai/papers/10.3390/jcm12154978
The paper
Kotfis, K., Wojciechowska, A., Zimny, M., Jamioł-Milc, D., Szylińska, A., Kwiatkowski, S., Kaim, K., Dołęgowska, B., Stachowska, E., Zukowski, M., Pankowiak, M., Torbé, A., & Wischmeyer, P. (2023). Preoperative oral carbohydrate (CHO) supplementation is beneficial for clinical and biochemical outcomes in patients undergoing elective cesarean delivery under spinal anaesthesia-a randomized controlled trial. Journal of Clinical Medicine. https://doi.org/10.3390/jcm12154978

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.